Close
4

Quotient Sciences Quotient Sciences

X

Company profile for Aerpio Pharmaceuticals

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Aerpio Pharmaceuticals is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. Our lead product candidate, AKB-9778, is a Tie2 activator being developed for the treatment of diabetic eye disease. AKB-9778 is currently in a Phase 2b study (TIME-2b) for the treatment of non-proliferative diabetic retinopathy (NPDR), a disease that affects millions of people across the globe. An innovati...
Aerpio Pharmaceuticals is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. Our lead product candidate, AKB-9778, is a Tie2 activator being developed for the treatment of diabetic eye disease. AKB-9778 is currently in a Phase 2b study (TIME-2b) for the treatment of non-proliferative diabetic retinopathy (NPDR), a disease that affects millions of people across the globe. An innovative approach targeting the Tie2 pathway: Subcutaneous AKB-9778 for the treatment of non-proliferative diabetic retinopathy (NPDR).

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Aerpio Pharmaceuticals
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
9987 Carver Road, Suite 420 Cincinnati, OH 45242
Telephone
Telephone
+1 513.985.1920
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY